Avalon/GSK Incubation Project Launches First Company, Focused On Celiac Disease

New company Sitari will try to develop first drug therapy for celiac disease. Portfolio companies launched by GSK and Avalon also will have their own, dedicated CRO-like organization to handle much of their work.